OS Therapies Incorporated

AMEX:OSTX

Biotechnology

Healthcare
$1.15 +5.81%

+$0.10 today

Market cap
$53.83M
Beta
-0.95
P/E (TTM)
-2.0
EPS (TTM)
-$0.91
52W Low $1.15High $2.57

Volume 0.50M

Average 0.71M

Balance Sheet

Inspect the capital base behind the business.

Assets

$6.84M

FY 2025 · Annual

+23.5% YoY

Liabilities

$12.94M

FY 2025 · Annual

+173.6% YoY

Equity

-$6.10M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents80.79K171.48K38.98K5.53M269.83M
Short-term Investments00000
Net Receivables231.07K1.15K000
Inventory00000
Other Current Assets956K324.21K751.05K0(269.56M)
Total Current Assets312.82K496.84K790.03K5.53M332.91K
Property, Plant & Equipment (Net)13.08K12.27K8.05K5.27K2.49M
Goodwill00000
Intangible Assets00006.5M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets000(0)(2.49M)
Total Non-current Assets13.08K12.27K8.05K5.27K6.51M
Total Assets325.89K509.11K798.08K5.54M6.84M
Account Payables856.52K1.23M2.72M1.66M9.94M
Short-term Debt0014.61M00
Tax Payables367.02K426.01K000
Deferred Revenue00000
Other Current Liabilities1.61M3.04M4.71M2.35M0
Total Current Liabilities3.5M6.15M24.71M4.63M11.76M
Long-term Debt7.07M10.35M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)100K100K100K0100K
Other Non-current Liabilities1.11M1.47M100K100K1.07M
Total Non-current Liabilities8.28M11.92M100K100K1.17M
Total Liabilities11.78M18.07M24.81M4.73M12.94M
Common Stock9.98K4.99K5.34K20.87K37.12K
Retained Earnings(15.22M)(21.6M)(29.52M)(40.4M)(67.19M)
Accumulated OCI00000
Other Stockholders Equity000(0)0
Minority Interest00000
Total Equity(11.45M)(17.56M)(24.02M)811.49K(6.1M)
Total Debt7.07M10.35M14.61M00
Net Debt6.99M10.18M14.57M(5.53M)(269.83M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$917.6M
Other Current-$916.6M
Total Current Assets$917.6K
PP&E (Net)$1.8M
Intangible Assets$6.4M
Other Non-current-$1.8M
Total Non-current Assets$6.4M
Total Assets$7.3M

Analysis

Selected assets total $7.3M for Latest. The largest visible component is Cash & Equivalents at $917.6M, about 12570.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026

How much cash does OSTX have?

OS Therapies Incorporated (OSTX) reported $269.83M in cash and equivalents in fiscal 2025.

How much debt does OSTX carry?

OS Therapies Incorporated (OSTX) reported $0.00 of total debt, with net debt of -$269.83M.